UPDATE: Cantor Fitzgerald Assumes Aziyo Biologics Inc. (AZYO) at Overweight, PT Lowered to $12
Tweet Send to a Friend
(Updated - May 27, 2022 6:35 AM EDT)
Cantor Fitzgerald analyst Ross Osborn assumed coverage on Aziyo Biologics Inc ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
Cantor Fitzgerald analyst Ross Osborn assumed coverage on Aziyo Biologics Inc ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
